
Chapter 46 THYROID AND ADRENAL DISORDERS326
39. When should the diagnosis of pheochromocytoma be considered?
A diagnosis of pheochromocytoma should be considered in a patient who has the typical
symptoms and severe hypertension, especially episodic hypertension, hypertension that requires
four or more medications to control, or hypertension that began before the age of 35 years or
after age 60. Patients who are hypertensive and have a family history of severe episodic
hypertension, or components of multiple endocrine neoplasia type 2 (medullary thyroid cancer,
hyperparathyroidism, and pheochromocytoma) should also be considered at risk.
40. What is unique about the treatment of hypertension in a patient with
pheochromocytoma?
The most important thing to remember is to not use beta blockers as a first-line treatment
when a diagnosis of pheochromocytoma is being considered. This is because b-blockade will
result in unopposed a-receptor activation, which will increase vasoconstriction and worsen
hypertension. Pure vasodilators can be used in the acute setting. It is important to institute
good a-blockade early using medications such as phenoxybenzamine or prazosin. Labetalol
has the advantage of having both a- and b-blocking activities and is also useful in this setting.
WEBSITES
1. Adrenal insufficiency and adrenal crisis: www.emedicine.com.
2. American Association of Clinical Endocrinologists: www.aace.com.
3. American Thyroid Association: www.thyroid.org.
4. Hyperthyroidism, thyroid storm, and Graves disease: www.emedicine.com.
5. Myxedema coma or crisis: www.emedicine.com.
6. Thyroid Disease Manager: www.thyroidmanager.org
BIBLIOGRAPHY
1. Beale MB, Belzberg H: Adrenal insufficiency. In Grenvik A, editor: Textbook of critical care, ed 4, Philadelphia,
2000, W. B. Saunders, pp 806–816.
2. Bravermann LE, Burch HB, Wartofsky L: Life-threatening thyrotoxicosis-thyroid storm. Endocrinol Metab Clin
North Am 22:263–277, 1993.
3. Braverman LE, Utigar RD, Werner SC, et al, editors: Werner and Ingbar’s the thyroid: a fundamental and
clinical text, ed 8, Philadelphia, 2000, Lippincott Williams & Wilkins.
4. Cooper MS, Stewart PM: Corticosteroid insufficiency in acutely ill patients. N Engl J Med 348:727–734, 2003.
5. Hegedus L: The thyroid nodule. N Engl J Med 351:1764–1771, 2004.
6. Hermus AR, Huysmans DA: Treatment of benign nodular thyroid disease. N Engl J Med 338:1438–1446, 1998.
7. Jordan RM: Myxedema coma: pathophysiology, therapy, and factors affecting prognosis. Med Clin North Am
79:185–194, 1995.
8. Lamberts SWJ, Bruining HA, de Jong FH: Corticosteroid therapy in severe illness. N Engl J Med 337:1285–1292,
1997.
9. Loriaux DL, McDonald WJ: Adrenal insufficiency. In DeGroot LJ, editor: Endocrinology, ed 4, vol. 2.
Philadelphia, 2001, W. B. Saunders,, pp 1683–1690.
10. Oelkers W: Adrenal insufficiency. N Engl J Med 335:1206–1212, 1996.
11. Pimentel L, Hansen KN: Thyroid disease in the emergency department: a clinical and laboratory review.
J Emerg Med 28:201–209, 2005.
12. Tietgens ST, Leinung MC: Thyroid storm. Med Clin North Am 79:169–184, 1995.
13. Weetman AP: Medical progress: Grave’s disease. N Engl J Med 343:1236–1248, 2001.
14. Wogan JM: Selected endocrine disorders. In Marx JA, Hockberger R, Walls R, et al, editors: Rosen’s
emergency medicine: concepts and clinical practice, ed 5, St. Louis, 2002, Mosby, pp 1770–1785.